562 related articles for article (PubMed ID: 30575798)
1. Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation.
Norris PC; Skulas-Ray AC; Riley I; Richter CK; Kris-Etherton PM; Jensen GL; Serhan CN; Maddipati KR
Sci Rep; 2018 Dec; 8(1):18050. PubMed ID: 30575798
[TBL] [Abstract][Full Text] [Related]
2. Quantitative profiling of inflammatory and pro-resolving lipid mediators in human adolescents and mouse plasma using UHPLC-MS/MS.
Hartling I; Cremonesi A; Osuna E; Lou PH; Lucchinetti E; Zaugg M; Hersberger M
Clin Chem Lab Med; 2021 Oct; 59(11):1811-1823. PubMed ID: 34243224
[TBL] [Abstract][Full Text] [Related]
3. Effects of prenatal n-3 fatty acid supplementation on offspring resolvins at birth and 12 years of age: a double-blind, randomised controlled clinical trial.
See VHL; Mas E; Prescott SL; Beilin LJ; Burrows S; Barden AE; Huang RC; Mori TA
Br J Nutr; 2017 Dec; 118(11):971-980. PubMed ID: 29173199
[TBL] [Abstract][Full Text] [Related]
4. Effects of postnatal omega-3 fatty acid supplementation on offspring pro-resolving mediators of inflammation at 6 months and 5 years of age: A double blind, randomized controlled clinical trial.
See VHL; Mas E; Prescott SL; Beilin LJ; Burrows S; Barden AE; Huang RC; Mori TA
Prostaglandins Leukot Essent Fatty Acids; 2017 Nov; 126():126-132. PubMed ID: 29031390
[TBL] [Abstract][Full Text] [Related]
5. Over-the-counter fish oil supplementation and pro-resolving and pro-inflammatory lipid mediators in rheumatoid arthritis.
Marchand NE; Choi MY; Oakes EG; Cook NR; Stevens E; Gomelskaya N; Kotler G; Manson JE; Lasky-Su J; Mora S; Lee IM; Tatituri R; Costenbader KH
Prostaglandins Leukot Essent Fatty Acids; 2023 Mar; 190():102542. PubMed ID: 36773395
[TBL] [Abstract][Full Text] [Related]
6. Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation.
Mas E; Croft KD; Zahra P; Barden A; Mori TA
Clin Chem; 2012 Oct; 58(10):1476-84. PubMed ID: 22912397
[TBL] [Abstract][Full Text] [Related]
7. Metabololipidomic profiling of functional immunoresolvent clusters and eicosanoids in mammalian tissues.
Norris PC; Serhan CN
Biochem Biophys Res Commun; 2018 Oct; 504(3):553-561. PubMed ID: 29524409
[TBL] [Abstract][Full Text] [Related]
8. Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors.
Keelan JA; Mas E; D'Vaz N; Dunstan JA; Li S; Barden AE; Mark PJ; Waddell BJ; Prescott SL; Mori TA
Reproduction; 2015 Feb; 149(2):171-8. PubMed ID: 25504868
[TBL] [Abstract][Full Text] [Related]
9. The effect of n-3 fatty acids and coenzyme Q10 supplementation on neutrophil leukotrienes, mediators of inflammation resolution and myeloperoxidase in chronic kidney disease.
Barden AE; Shinde S; Burke V; Puddey IB; Beilin LJ; Irish AB; Watts GF; Mori TA
Prostaglandins Other Lipid Mediat; 2018 May; 136():1-8. PubMed ID: 29577973
[TBL] [Abstract][Full Text] [Related]
10. Specialised pro-resolving mediators of inflammation in inflammatory arthritis.
Barden AE; Moghaddami M; Mas E; Phillips M; Cleland LG; Mori TA
Prostaglandins Leukot Essent Fatty Acids; 2016 Apr; 107():24-9. PubMed ID: 27033423
[TBL] [Abstract][Full Text] [Related]
11. Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue.
Colas RA; Shinohara M; Dalli J; Chiang N; Serhan CN
Am J Physiol Cell Physiol; 2014 Jul; 307(1):C39-54. PubMed ID: 24696140
[TBL] [Abstract][Full Text] [Related]
12. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
Serhan CN; Libreros S; Nshimiyimana R
Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568
[TBL] [Abstract][Full Text] [Related]
13. Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation.
Lamon-Fava S; So J; Mischoulon D; Ziegler TR; Dunlop BW; Kinkead B; Schettler PJ; Nierenberg AA; Felger JC; Maddipati KR; Fava M; Rapaport MH
Prostaglandins Leukot Essent Fatty Acids; 2021 Jan; 164():102219. PubMed ID: 33316626
[TBL] [Abstract][Full Text] [Related]
14. Enriched Marine Oil Supplements Increase Peripheral Blood Specialized Pro-Resolving Mediators Concentrations and Reprogram Host Immune Responses: A Randomized Double-Blind Placebo-Controlled Study.
Souza PR; Marques RM; Gomez EA; Colas RA; De Matteis R; Zak A; Patel M; Collier DJ; Dalli J
Circ Res; 2020 Jan; 126(1):75-90. PubMed ID: 31829100
[TBL] [Abstract][Full Text] [Related]
15. Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid.
Markworth JF; Kaur G; Miller EG; Larsen AE; Sinclair AJ; Maddipati KR; Cameron-Smith D
FASEB J; 2016 Nov; 30(11):3714-3725. PubMed ID: 27461565
[TBL] [Abstract][Full Text] [Related]
16. Specialized proresolving lipid mediators in humans with the metabolic syndrome after n-3 fatty acids and aspirin.
Barden AE; Mas E; Croft KD; Phillips M; Mori TA
Am J Clin Nutr; 2015 Dec; 102(6):1357-64. PubMed ID: 26561623
[TBL] [Abstract][Full Text] [Related]
17. Identification and Profiling of Specialized Pro-Resolving Mediators in Human Tears by Lipid Mediator Metabolomics.
English JT; Norris PC; Hodges RR; Dartt DA; Serhan CN
Prostaglandins Leukot Essent Fatty Acids; 2017 Feb; 117():17-27. PubMed ID: 28237084
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and Changes in Lipid Mediator Profiling after Consumption of Specialized Pro-Resolving Lipid-Mediator-Enriched Marine Oil in Healthy Subjects.
Irún P; Carrera-Lasfuentes P; Sánchez-Luengo M; Belio Ú; Domper-Arnal MJ; Higuera GA; Hawkins M; de la Rosa X; Lanas A
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003333
[TBL] [Abstract][Full Text] [Related]
19. Regression of human coronary artery plaque is associated with a high ratio of (18-hydroxy-eicosapentaenoic acid + resolvin E1) to leukotriene B
Welty FK; Schulte F; Alfaddagh A; Elajami TK; Bistrian BR; Hardt M
FASEB J; 2021 Apr; 35(4):e21448. PubMed ID: 33749913
[TBL] [Abstract][Full Text] [Related]
20. Fish Oil Increases Specialized Pro-resolving Lipid Mediators in PAD (The OMEGA-PAD II Trial).
Ramirez JL; Gasper WJ; Khetani SA; Zahner GJ; Hills NK; Mitchell PT; Sansbury BE; Conte MS; Spite M; Grenon SM
J Surg Res; 2019 Jun; 238():164-174. PubMed ID: 30771686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
